Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...

Chicago, IL - Only one guideline-defined risk factor for sudden cardiac death (SCD) can be enough to consider patients with hypertrophic cardiomyopathy (HCM) for a primary-prevention implantable ...

Please provide your email address to receive an email when new articles are posted on . The following risk scores and recommendations for an ICD implant were compared: 2014 ESC risk scoring model, ...

Researchers at Tufts Medical Center report reassuring accuracy predicting which patients with a common genetic heart disease are at the most risk of sudden death and thus most need an implanted device ...

Please provide your email address to receive an email when new articles are posted on . Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023. Readers were ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Hypertrophic cardiomyopathy (HCM) is often seen in patients as an autosomal dominant genetic heart disease with a variable clinical course. It is characterized by left ventricular hypertrophy, and ...